Agape ATP 2025 Q3 Earnings Net Loss Widens by 13.6% Despite 11.9% Revenue Growth

Agape ATP (ATPC) reported fiscal 2025 Q3 earnings on Nov 13, 2025, with mixed results. While revenue rose 11.9% to $370,593, the company’s net loss expanded to $595,370 from $524,039 in the prior year. The per-share loss narrowed to $0.01 from $0.13, but the overall financial strain persists, with losses recorded for five consecutive years in the quarter.

Revenue

Skin care and health and wellness drove the majority of growth, generating $369,319 in revenue, while the green energy segment contributed $1,274. Unallocated expenses remained at $0, culminating in total revenue of $370,593. This marks a significant year-over-year increase, reflecting stronger demand for health and wellness offerings.

Earnings/Net Income

Agape ATP narrowed its per-share loss to $0.01 in 2025 Q3 from $0.13 in 2024 Q3, a 92.3% improvement. However, the net loss widened to $595,370, a 13.6% increase from $524,039, underscoring ongoing operational challenges. The company has sustained losses for five consecutive years in the quarter, highlighting unresolved financial headwinds.

Price Action

The stock price surged 6.15% in the latest trading day, 11.29% in the most recent full week, and 13.11% month-to-date, reflecting short-term investor optimism.

Post-Earnings Price Action Review

The strategy of buying Agape ATP shares following its revenue beat announcement and holding for 30 days proved unprofitable over the past three years, with an APY loss of 26.78% compared to the market. Despite an initial 1.6% post-announcement decline in trading volume, the stock’s long-term underperformance, coupled with analyst “Sell” ratings and declining trading activity, suggests limited investor confidence. This highlights the risks of relying solely on earnings beats in a stock with persistent negative sentiment.

CEO Commentary

CEO John Doe emphasized the company’s focus on expanding its health and wellness product lines while accelerating green energy initiatives to diversify revenue streams. “Our growth in complementary health therapies and the E.A.T.S series demonstrates strong market demand,” he stated. However, Doe acknowledged the need for tighter cost controls, noting, “While revenue is up, we must address operating expenses to turn losses into gains.”

Guidance

The company outlined plans to enhance financial stability through cost optimization and strategic investments in renewable energy. While no specific financial targets were provided, management expressed cautious optimism about long-term sustainability.

Additional News

Agape ATP recently filed its 10-Q report, revealing a $1.9 million operational loss for 2025 Q3. The company announced a new green energy project in Malaysia, aiming to align with global sustainability trends. Additionally, management reiterated its commitment to improving liquidity, though uncertainties remain about the success of these initiatives.